NeoTX Therapeutics Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.

Company Highlights
Year Founded

2015

icon-altEmployees

18

Location (HQ)

ISR

Since Last Funding

4 years 8 months

Monthly Website Visitors

4.0K

icon-altTotal Investment Amt

$65M

Last Funding Round

Series C

icon-altMoM Headcount Growth

5.85%

icon-altYoY Headcount Growth

-49.86%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Therapeutics

Health Care

Biotechnology Research

Medical

Health Diagnostics

Oncology